#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Glen Kashuba Email
CEO . Cerapedics
How to contact Glen Kashuba
Join and see Glen's contact info for free!Current Roles
Employees:
310Revenue:
$67.3MAbout
Cerapedics is an advanced orthobiologics company focused on developing its proprietary biomimetic small peptide molecule (P-15) for commercialization in spinal applications. i-FACTOR Peptide Enhanced Bone Graft (P-15/ABM) is only the 2nd FDA PMA Approve bone graft on the market, and it has shown statistical superiority to local autograft through an IDE trial on single-level ACDFs in overall clinical success at one year. i-FACTOR is the only biologic bone graft in orthopedics that incorporates a small peptide as an attachment factor to stimulate the natural bone healing process. This novel mechanism of action (Attract, Attach, Activate) is designed to support safer and more predictable bone formation compared to other commercially available bone growth factors.Cerapedics Address
11025 Dover StreetWestminster, CO
United States